There is 1 paper on WID-qEC in aging research: 1 observational study in people.
1 paper studies it2 findings
“WID-qEC positivity was associated with the presence of ovarian cancer (adjusted odds ratio [OR] 2.93; 95% CI 1.75-4.95)”
- Humans1
Associations
2Lifetime ovulatory cycles
upin humans1OR 2.67
1 study
Lifetime ovulatory cycles
upin humans1OR 2.67
WID-qEC is associated with lifetime ovulatory cycles in women without endometrial or cervical cancer (adjusted OR 2.67; 95% CI 1.06-7.50).
“and with a higher number of lifetime ovulatory cycles (adjusted OR 2.67; 95% CI 1.06-7.50), a known ovarian cancer risk factor.”
Humansin women without endometrial or cervical cancerfemalesn = 1,269
International journal of cancer
Ovarian cancer
upin humans1OR 2.93
1 study
Ovarian cancer
upin humans1OR 2.93
WID-qEC is associated with ovarian cancer in women without endometrial or cervical cancer (adjusted OR 2.93; 95% CI 1.75-4.95).
“WID-qEC positivity was associated with the presence of ovarian cancer (adjusted odds ratio [OR] 2.93; 95% CI 1.75-4.95)”
Humansin women without endometrial or cervical cancerfemalesn = 1,269
International journal of cancer
Latest
1 paper in 12 monthsInternational Journal of Cancer
The cervico-vaginal DNA methylation WID-qEC test: An epigenetic marker associated with ovarian cancer in the absence of endometrial and cervical cancer
Case-control study of 1,269 peopleOvarian cancer